Metri Bio's CEO, Ashley Abel, selected for Forbes 30 Under 30

Metri Bio Raises $5M Pre-Seed to Develop Endometriosis Therapeutics

News

Michele Keough Joins Metri Bio as Chief Operating Officer

July 22, 2026

Metri Bio CEO Ashley Abel Selected for the 2026 Termeer Fellowship

March 24, 2026

Metri Bio’s CEO, Ashley Abel, selected for Forbes 30 Under 30

January 1, 2026

Metri Bio Raises $5M Pre-Seed to Develop Endometriosis Therapeutics

December 2, 2025

Our mission

Metri Bio is working to radically improve the lives of people suffering from diseases that impact the endometrium.